For the fourth quarter of 2019, WW Soft Tissue Fixation Market revenue was up +3.7% YoY. Aggregate growth for the quarter especially benefited from healthy and continued revenue gains in the Hip Labral repair segment, which was up +8.9% YoY. And, to a smaller extent, the Meniscal repair and the Shoulder repair segments also contributing to the overall WW market growth in Q419 with YoY increases of 4.4% and 4.1%, respectively, based on SmartTRAK Financial Dashboard. Similar to other orthopedic markets, such as the Joint replacement market, Soft Tissue Fixation is typically seasonal with lower sales during Q3 and recovery in Q4 driven by a year-end increase in the number of elective procedures and stronger product push as competitors race to finish the year at or above their respective budget projections.
- Complete Market Overview and Highlights
- Competition: The Veterans and the Newbies – How Did Players Do?
- Arthrex Leads the US Soft Tissue Fixation Market
- Smith & Nephew's Solid Growth
- Depuy Synthes' Growth Momentum in US Knee Joint Replacement
- Zimmer Biomet: Righting the Ship
- Stryker's Solid Performance
- Q419 Clinical & Regulatory Highlights
Focusing on the US region, which holds the largest revenue share of the total WW Soft Tissue Fixation market, revenue in this key geographic area reached
$ for Q419 and $ for FY19, based on SmartTRAK Financial Dashboard. The US Soft Tissue Fixation market typically experiences higher revenue in Q4 considering that in Sports Medicine as it is with other orthopedic specialties higher volumes of elective surgeries are performed at this time of the year.
Read the complete, comprehensive Q419/FY19 Soft Tissue Fixation Market Recap including news, financial data, charts, company revenues and shares, plus insightful analysis from our team of experts*...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.